ArticleJournal of biological engineering2025
Combinatorial engineering pinpoints shikimate pathway bottlenecks in para-aminobenzoic acid production in Pseudomonas putida.
Article in Journal of biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Combinatorial expression libraries to optimize multigene pathways can improve product titers, but the large number of potential genetic variants makes exhaustive testing impractical. Statistical Design of Experiments (DoE) offers a powerful alternative to enable efficient exploration of gene expression landscapes with a limited number of measurements. Here, we applied this approach to modulate expression levels across all genes in the shikimate and para-aminobenzoic acid (pABA) biosynthesis pathways in Pseudomonas putida. From a theoretical library of 512 strain variants, we trained a regression model using a statistically structured sample comprising 2.7% of the total library, as defined by our DoE approach, and used the model to predict new genotypes with improved pABA titers. This strategy enabled us to achieve product titers ranging from 2 to 186.2 mg/L in the initial screen and subsequently guide a second round of strain engineering, culminating in a maximum titer of 232.1 mg/L. Our analysis indicated that aroB, encoding 3-dehydroquinate synthase, is a critical bottleneck in pABA biosynthesis. This study highlights the utility of combining DoE with linear regression modeling to systematically optimize complex metabolic pathways, paving the way for more efficient microbial production.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.